|
HOW AI IS SHAPING THE FUTURE OF THE PHARMACEUTICAL INDUSTRY article Dec 02, 2019 Artificial Intelligence and Machine Learning are powering incredible changes across a huge range of industries. But in data and research-dependent industries such as pharmaceuticals, they’re having an unparalleled impact. From improving candidate selection processes for clinical trials, to acc... Read More |
COULD AI CREATE A BRAVE NEW WORLD OF PHARMA R&D? article Nov 29, 2019 Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Richard Staines looks at the progress already made thanks to this potentially revolutionary technology, and how it could change the fortunes of a beleaguered pharma industry. Artificial I... Read More |
SILOS IN PHARMA – THE DATA ISSUE article Nov 28, 2019 A key component of product innovation in the pharmaceutical industry is the analysis of data. Yet, the Pharma industry can be diagnosed as suffering with one particular problem: the prevalence of data silos. Often stored across disparate tools and locations, the isolation of data severely impacts th... Read More |
MODERN PHARMA GROWS MORE COLOURFUL article Nov 28, 2019 The modern pharmacy retail segment is welcoming an exciting new entrant in Japanese drug and cosmetics retailer Matsumotokiyoshi Co., Ltd, urging existing players to dust down their racing goggles. Matsumotokiyoshi has agreed to form a joint venture with Lotus Food Group JSC to operate a drugstore c... Read More |
A SAFER RIDE: THE LATEST INNOVATION IN TARGETED CANCER TREATMENT article Nov 28, 2019 One downside of the antibody-drug conjugates used in oncology today is that the drug-carrying antibodies can shed much of their toxic cargo on the way to the tumour site. Now, German researchers have published their method for attaching drugs to antibodies with greater stability, potentially making ... Read More |
WHERE THE NURSE PRESCRIBES HEROIN article Nov 27, 2019 A new program in Glasgow will give drug users pharmaceutical-grade heroin twice daily in a bid to reduce drug-related deaths. Homeless drug users in Scotland will be allowed to inject pharmaceutical-grade heroin twice a day under the supervision of medical officials as part of a new program intended... Read More |
HOW DOES CBD AFFECT YOUR MEMORY? article Nov 27, 2019 One of the great benefits of smoking marijuana is that there’s rarely any hangovers on the following day. Sadly, the plant still has the capability of rattling your memories. Cannabis, or THC more precisely, tends to affect people’s cognitive function and short term memory skills, which ... Read More |
PHARMACEUTICAL INDUSTRY IS ADOPTING AI ON NUMEROUS FRONTS article Nov 25, 2019 The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and safety monitoring, regulatory, and manufacturing. Pharmaceutical and biotechnology companies, as well as service providers now, rely on AI technolog... Read More |
4 COMMON MISCONCEPTIONS ABOUT COLD CHAIN LOGISTICS article Nov 22, 2019 When it comes to shipping pharmaceuticals, we use cold chain materials to control the temperature of your drugs or medicines from the manufacturer through a delivery to the end user. It’s critical to keep these within the proper temperature range because they can be rendered useless or even ha... Read More |
PHARMA COLD CHAIN TRACKING : A PROTOTYPE article Nov 22, 2019 Innovation with the Internet of Things(IoT) has been an on-going effort. Although IoT appeared in the Gartner hype cycle for 2017, it has been around for a very long time and businesses have experimented with this technology since the time we can remember. It’s only in the recent past that cos... Read More |
ARE MEDTECH COMPANIES READY FOR THE ROBOTICS DIGITAL DATA REVOLUTION? article Nov 22, 2019 The ultimate value that robotics data will provide is in improving outcomes through better recording of process, approach, measurements and outcomes data. Collected through an individual robot in one OR, that data is likely interesting, but not significantly valuable. It’s also not linked to t... Read More |
DIGITAL TRANSFORMATION: A GUIDE FOR PHARMA MARKETERS article Nov 21, 2019 Artificial intelligence (AI) and machine learning (ML) are not yet perfect sciences, but they are transforming life sciences companies in practical and meaningful ways. This includes improving targeting and relationships with healthcare providers (HCPs) and patients. However, organizations need to b... Read More |
5 THINGS A LANDLORD SHOULD KNOW ABOUT RECREATIONAL CANNABIS IN ILLINOIS article Nov 21, 2019 Registered qualifying patients under the Compassionate Use of Medical Cannabis Pilot Program Act, are granted certain exceptions for possession volume and cultivation of cannabis. Further, the CRTA does not permit any person to smoke cannabis in any place where smoking is already prohibited under th... Read More |
WHAT TO KNOW ABOUT CANNABIS ADVERTISING IN 2020 article Nov 21, 2019 If you are a business owner you might know advertising can be challenging at times, especially if you are an owner of a Cannabis Dispensary or CBD Shop. You are not sure where to start. You might ask yourself do I need someone to help me with this? What are the laws, rules and regulations for advert... Read More |
|
PHARMA CYBER SECURITY: HOW TO TACKLE MALWARE THREATS article Nov 20, 2019 The global pharmaceutical market is expected to grow to almost 1.2 billion by 2021,1 thanks in part to rapid advancements in digital automation and innovation. Unfortunately, these growth-generating strategies also open pharma manufacturers up to new risks. For example, acquisitions and outsourcing ... Read More |
SEARCHING CHEMICAL SPACES TO BOOST DRUG DEVELOPMENT article Nov 20, 2019 In drug discoverers’ jargon, large collections of molecules are known as chemical spaces. Whereas chemical spaces only contained a few million molecules some years ago, they now hold tens of billions of molecules. In addition, previously “virtual” molecules can now be purchased and... Read More |
MINIMIZING RISK WITHIN THE PHARMACEUTICAL SUPPLY CHAIN article Nov 19, 2019 The U.S. pharmaceutical supply chain is responsible for providing patients safe, secure and timely access to more than 4 billion prescription medicines every year. Sustaining this complex supply chain requires the collaboration between a diverse group of partners, including manufacturers, distributo... Read More |
5 ESSENTIALS FOR A SUCCESSFUL PHARMACEUTICAL ADVISORY BOARD MEETING article Nov 19, 2019 It happens all the time across the pharmaceutical industry: you’ve been tasked with understanding customer perceptions better, but your budget and timelines are limited. In these situations, an Advisory Board can be an incredibly valuable tool. Advisory Board meetings help manufacturers seek a... Read More |
THE MEDICINE PLANT THAT COULD HAVE CHANGED THE WORLD. article Nov 18, 2019 Growing up in Tanzania, I knew that fruit trees were useful. Climbing a mango tree to pick a fruit was a common thing to do when I was hungry, even though at times there were unintended consequences. My failure to resist consuming unripened fruit, for example, caused my stomach to hurt. With such in... Read More |
FOUR PREDICTIONS ON THE FUTURE OF PERSONALISED MEDICINE article Nov 18, 2019 For as long as there have been people, there have been illness and disease to hobble them. From cancer to the common cold, these nemeses of the human condition aren’t just going to disappear overnight. But medical researchers are still making major headway in how we diagnose and treat differen... Read More |
WELCOME TO THE FUTURE OF PHARMA article Nov 18, 2019 Innovation in pharma is playing a key role in transforming science, healthcare and even the wider society. From the chance discovery of penicillin to the Human Genome Project – one of the world’s largest collaborative scientific endeavours – we have seen the eradication of devastat... Read More |
WHAT LOWER PRICES WOULD MEAN FOR DRUG COMPANIES? article Nov 15, 2019 Drug pricing regulations would not decimate the pharmaceutical industry, according to an analysis from health policy researchers at West Health and Johns Hopkins. This throws some cold water on Big Pharma's claims that new drug research and investments would evaporate if the federal government l... Read More |
HOW BIG PHARMA AND STARTUPS CAN LEARN FROM EACH OTHER article Nov 15, 2019 The way to accelerate benefit to patients changes over time as technology improves and innovation becomes more cutting edge. I’ve always looked for the more cutting-edge projects because, quite frankly, they’re just more intellectually stimulating for me. I like being on the vanguard whe... Read More |
|
DOES YOUR SCIENTIFIC NARRATIVE RESONATE IN THE PHARMACEUTICAL ECOSYSTEM? article Nov 14, 2019 Pharmaceutical communication is a foundational component of stakeholder engagement and management. In Europe, pharmaceutical communication traditionally focuses solely on interaction with prescribers, while in the US pharma communication also includes direct-to-consumer advertising. Strategic engage... Read More |
IMPROVING MEDICINES ADHERENCE WITH VR article Nov 12, 2019 With medicine adherence still a major problem for pharma and healthcare systems, a collaboration between Cognitant Group and Addenbrooke’s Hospital –supported by grants from UCB and Pfizer – is piloting a programme that aims to educate patients through the power of virtual reality ... Read More |
WHY ETHANOL WORKS SO WELL FOR CANNABIS EXTRACTION article Nov 12, 2019 Cannabis comes with a lot of known health benefits to users with little to no side effects, unlike pharmaceutical drugs. Advancement in technology now allows manufacturers to extract various products infused within cannabis such as extracts, concentrates, edibles, etc. The use of ethanol in extracti... Read More |
COULD CANNABINOIDS BE USED TO TREAT PTSD? article Nov 12, 2019 The use of cannabinoids to treat PTSD is becoming a much more common treatment regime. Historically, cannabinoids were difficult to prescribe, as national legislation restricted scientists from studying their therapeutic efficacy. Without this research and with the lack of a product monograph, in th... Read More |
|
THE IMPACT OF SYNTHESIS INNOVATION IN DRUG DISCOVERY article Nov 11, 2019 The term "process chemistry" describes the action of "scaling up" reactions – taking small quantities of a chemical compound and synthesizing it on a much greater scale. A process chemist is tasked with developing synthetic routes that are safe, cost-effective and efficient... Read More |
COLLABORATION IS THE X FACTOR IN MAKING PRECISION MEDICINE A SUCCESS article Nov 11, 2019 Last year, the FDA approved 59 new molecular entities for the US market, the highest number ever approved in a single year. A key driver of this record level of approvals is the explosive growth of precision medicine. Since 2015, at least a fifth of all new drug approvals each year have been precisi... Read More |
INTELLIGENT DRUG DISCOVERY: POWERED BY AI article Nov 08, 2019 Drug discovery is the process of identifying new medicines for treating or curing human diseases. While drug discovery has led to many life-saving and life-enhancing clinical treatments, historically the process has also been long, expensive, and often unsuccessful, with many areas of unmet need sti... Read More |
VIRTUAL PHARMA – NOW FOR REAL? article Nov 08, 2019 Over the last decades, the advances in medical science, the growing competition and the demands of the payers have led to permanent changes and adaptations of the pharma business model. Even the biggest companies do not do everything in-house. Instead, the industry has developed partnering as one ke... Read More |
WHAT IS ALLOMETRIC SCALING AND HOW DOES IT SUPPORT DRUG DEVELOPMENT? article Nov 06, 2019 There are many aspects of drug development that must be understood before a drug can be tested in humans. Nonclinical studies are conducted to understand the safety (i.e., toxicity and safety pharmacology) of drug candidates and to provide critical pharmacokinetic (PK) information, including insight... Read More |
|
FIRST NEW HIV STRAIN IN 19 YEARS IDENTIFIED article Nov 06, 2019 A research group at the medical devices and health care giant Abbott has discovered a new strain of human immunodeficiency virus, or HIV—the first to be identified in 19 years. Abbott continues to look for potential new HIV strains to ensure that diagnostic tests for blood screening and detect... Read More |
A PHARMA FIRST: FDA-APPROVED APP FOR TREATMENT OF ADDICTION article Nov 06, 2019 It’s 2019. If technology is integrated into our daily lives when it comes to work, entertainment, and even social interactions, it shouldn’t come as a surprise that tech is also playing a major role in improving health outcomes. A 2018 study showed that 90% of Americans use digital healt... Read More |
CANCER DRUG DISCOVERY: UNRAVELLING THE MYSTERIES OF HALICHONDRIN article Nov 05, 2019 A joint Harvard-Eisai project has achieved a breakthrough by fully synthesising the highly potent anti-cancer molecule halichondrin, sourced from marine sponges, at scale. It has taken 30 years of research to reach this point, so what has made halichondrin synthesis so difficult, and what are the im... Read More |
MISTAKES TO BE AVOIDED WHEN PREPARING A DRUG LAUNCH article Nov 05, 2019 The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new products on the market, chances are that not one initiative entirely resembled another. For better or for worse, there is not a single recipe for su... Read More |
|
|
WE NEED MORE THAN NEW ANTIBIOTICS TO FIGHT RESISTANCE article Nov 01, 2019 Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs. In the summer of 1924, Calvin Jr., President Coolidge’s youngest son, developed a blister in his third right t... Read More |
ENFORCEMENT ACTIONS AGAINST SARTAN MANUFACTURERS article Oct 31, 2019 Health authorities worldwide have overseen the recall of many ‘sartan’ products in the past few years. These recalls began in the US as early as 2013 with a recall of product by Teva Pharmaceuticals. Authorities in the US, EMA, Canada, and Australia, just to name a few, have taken enforc... Read More |
PRECISION MEDICINE: HOW FAR WE’VE COME article Oct 30, 2019 A decade ago, precision medicine was little more than an idea and a phrase. The term was coined in 2011 by the National Research Council, a non-government agency that advises the government on scientific matters. That year, the NRC issued a report calling for a new “data network” to brin... Read More |
IS SEMANTIC TECHNOLOGY THE AI SWEET SPOT FOR PHARMA? article Oct 25, 2019 Artificial intelligence (AI) has been trumpeted by many in the pharmaceutical industry as the magic bullet to the issues they face in drug discovery and other research. However, expectations need to be tempered because although it’s easy to get excited by the potential of AI it’s importa... Read More |
DRUG HELPS PLANTS RESIST DROUGHT: STUDY article Oct 24, 2019 An engineered small molecule called opabactin that targets the receptor for the hormone abscisic acid (ABA), which plants release in stressful conditions, limited water loss in Arabidopsis, tomato, and wheat, and improved wheat’s tolerance of drought-like conditions in the lab, according to a ... Read More |
MULESOFT: HOW CAN API TOOLS SPEED UP DRUG DEVELOPMENT? article Oct 24, 2019 At its Connect conference in London in early October, MuleSoft brought together its customers and clients across all sectors to discuss how enterprise software, and particularly APIs, can drive efficiencies and contribute to digital transformation. Mulesoft’s David Chao and AstraZeneca’s... Read More |
|
CHANNELING THE POWER OF AI INTO PERSONALIZING MEDICINE article Oct 23, 2019 Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to bring personalized medicine to as many patients as possible? Kate Hilyard, COO of Healx in Cambridge in the UK, believes it can. Getting a drug to clinical trials currently requir... Read More |
DRUG DELIVERY article Oct 23, 2019 A drug’s efficacy can be impacted significantly by the way in which it is delivered. By developing a variety of drug delivery systems (DDSs) it is now possible to better control the pharmacokinetics, pharmacodynamics, toxicity, immunogenicity and efficacy of drugs. By finding the best-suited d... Read More |
|
DO PATIENTS CARE ABOUT WHAT YOUR DRUG DOES? article Oct 22, 2019 In most randomized pharmaceutical clinical trials, researchers are looking for a statistically significant performance difference between the two courses of therapy. But which is more important to the patient: Statistically significant improvement of a variable, or clinically significant improvement... Read More |
4 WAYS TO TALK WITH VACCINE SKEPTICS article Oct 21, 2019 Your neighbor is telling you about his new baby. He feels nervous about vaccinating, and says he's considering delaying Lucy's vaccines. Your mother's group is chatting about vaccines. One mother tells the group Jimmy isn't vaccinated, and she's using the Immune-Strengthening Die... Read More |
WHY IS PHARMA SO BAD AT SHARING CLINICAL TRIAL DATA? article Oct 21, 2019 Since the 90s, the requirements for pharmaceutical companies to register and report results from clinical trials have increased. But analysis published in the BMJ indicates that large pharmaceutical companies could be doing much more when it comes to sharing data. Over the last few decades, pharma c... Read More |
|
MEDICAL MARIJUANA AND THE DRUG-FREE WORKPLACE ACT article Oct 17, 2019 Presently 33 states and the District of Columbia have enacted medical marijuana laws. While some of these laws have been on the books for several years, the impact on employers and company policies are still evolving. This issue has created confusion for federal contractors who are required to compl... Read More |
COULD A UNIQUE NEW FUNGUS OFFER AN OPIOID ALTERNATIVE? article Oct 17, 2019 A new fungus discovered in the estuarine waters of Tasmania could be the unexpected answer to the world's opioid crisis, a current study suggests. Opioids — many of which are prescription painkillers, such as codeine — have created a worldwide health crisis. Many opioids are highly a... Read More |
WHAT ARE THE BENEFITS OF CBD? article Oct 16, 2019 The CBD industry is flourishing, conservatively projected to hit $16 billion in the United States by 2025. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. More than 60 percent of CBD users have taken it for anxiety, according to a survey of 5,000 people, con... Read More |
MAINTAINING PHARMACEUTICAL MANUFACTURING FACILITIES article Oct 16, 2019 The best ways to keep your facility clean. Pharmaceutical facilities, especially those manufacturing biological products or sterile dosage forms, present considerable cleaning challenges. They must be: designed to be cleanable and maintained, tested for cleanliness, and cleaned thoroughly. Read More |
WHICH BIG PHARMA FIRMS ARE BEST AT DIGITAL? article Oct 16, 2019 New research by The Worldcom Public Relations Group has ranked pharmaceutical companies according to their usage of digital channels – with Bayer, Pfizer and Boehringer Ingelheim coming out on top. However, the report – called the Digital Health Monitor – also notes that many large... Read More |
DIY DRUGS: SHOULD HOSPITALS MAKE THEIR OWN MEDICINE? article Oct 15, 2019 When a pharmaceutical company raised the price of an essential medicine to unacceptable levels, there was only one thing for pharmacist Marleen Kemper to do: start making it herself. When Kemper was in primary school, she had watched two of her classmates get ill. One had a brain tumour, the other c... Read More |
FIVE THINGS FOR PHARMA MARKETERS TO KNOW article Oct 15, 2019 Almost all patients with the vaping-related illness have ended up hospitalized, according to the Centers for Disease Control and Prevention. About half of people with the lung illness end up in the intensive care unit. Twenty-six people have died from the disease, and nearly 1,300 people have gotten... Read More |
|
CLINICAL GENETICS: A PART OF PHARMA’S DNA article Oct 14, 2019 Genetic testing has become an increasingly buoyant area for deal making in recent years. While the pharma industry has been experiencing price pressure and low R&D productivity, the recent market ambition for “Precision Medicine”1 has driven interest and growth in clinical genetics a... Read More |
IOT AND DRUG ADHERENCE: DIFFERENT APPROACHES TO CONNECTED SOLUTIONS article Oct 11, 2019 Sometimes it’s the really small things that make a huge difference to a person’s health. Skipping dosages of prescription medication, for example, has been linked to an array of negative effects. About half of us are guilty of not taking medication correctly, according to figures shared ... Read More |
METHOD “MATCHES” MEDICINES TO THEIR UNIQUE PROTEIN RECEPTORS article Oct 10, 2019 A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Having a method to determine exactly how different drug compounds target the same receptor is key to understanding why and... Read More |
MY PHARMACY PREREGISTRATION TRAINING PROVIDER WASN'T UP TO SCRATCH article Oct 10, 2019 Pharmacist preregistration trainees are full-time employees, so they need to adjust to a new work environment, study for the registration assessment and juggle their everyday commitments. The preregistration year is stressful, but for hard-working and disciplined individuals, it pays off. And in ret... Read More |
DRUG PRICES KILLING OR DISEASES? article Oct 10, 2019 The United States is a huge economy and the economies look up to it for inspiration on how to manage the country to yield maximum output from the economy. But the medicines and drugs in the country are something that has always been on the controversial aspects of the country. Read More |
IMPROVING MEDICINES SAFETY AS A VOLUNTEER PHARMACIST IN CAMBODIA article Oct 09, 2019 Cambodia remains one of the poorest countries in the world following the devastating activities of the Khmer Rouge regime of the 1970s, and the standard of its health care is variable. In 2018, I spent two weeks scoping out potential opportunities to improve patient safety at a provincial hospital i... Read More |
DEMONSTRATING DRUG POTENCY EARLY IN CELL THERAPY DEVELOPMENT article Oct 07, 2019 With traditional drug development, the FDA typically focuses the majority of its attention on clinical aspects of a drug. With advanced cell and gene therapies, the agency places far more focus on chemistry manufacturing and controls (CMC) much earlier in development. Due in part to the fact that th... Read More |
SHORTAGE OF DRUGS HAVING A SERIOUS IMPACT ON PRIMARY CARE article Oct 07, 2019 According to information gleaned from a drug tracker, more than 100 drugs regularly prescribed by GPs are now out of stock, and this is forcing patients to ‘chop and change’ between medicines. The tracker showed that a total of 106 products were unavailable earlier this month, while a fu... Read More |
CRITICAL STRATEGIES FOR DEVELOPING YOUR PHARMA TEAM article Oct 04, 2019 Effective teamwork is crucial for any pharmaceutical company. Whether it's an outstanding sales manager, establishing the company’s brand, or a medical advisor, managing clinical trials by company guidelines, everyone on your team needs to be engaged and focused on the same goals to facili... Read More |
TECHNOLOGY TOWARDS AN EFFICIENT MONITORING OF CLINICAL TRIALS article Oct 04, 2019 Clinical Study and Technology are two such genres that are progressing at a rapid rate. The implementation of age old practices does not suffice in any of the scenarios. Clinical trials are common in pharmaceutical industries and they occupy a major part in the approval of a drug. If the process of ... Read More |
RESEARCHERS HAVE DEVELOPED LAB-MADE THC AND CBD article Oct 02, 2019 When you smoke, vape, or eat cannabis, you obtain the cannabinoids THC and CBD from any of the thousands of different strains of cannabis plants. Until now, this was really the only way to get those cannabinoids, and trust me, it worked great. But a recent announcement from a man who knows more abou... Read More |
PHARMA MARKETING’S EVOLVING RELATIONSHIP WITH AI article Oct 02, 2019 How does artificial intelligence (AI) rank in the minds of pharmaceutical executives? How important is it in their eyes, and how does it compare to other trends? Although the buzz around AI has never been bigger, that’s not to say that every leader in pharma has bought into the hype yet. The D... Read More |
|
THE MARKET FOR UNBORN CHILDREN: BIG PHARMA, VACCINES AND TRAFFICKING OF ABORTED FETUSES article Oct 01, 2019 American family clinics, such as the Planned Parenthood Institute, first help women stop pregnancy . And immediately after, with half-closed doors, a very profitable journey begins. The aborted fetus is dissected in different parts, liver, kidney, thyme, skin, which are sold. A liver can cost up to ... Read More |
|
95% OF PEOPLE THINK THEY COULD DEVELOP DEMENTIA WITH AGE article Sep 30, 2019 A global study on attitudes toward dementia has shown that two-thirds of people believe it to be a natural risk of getting older, which could be limiting the help that people seek. Every 3 seconds, someone develops dementia somewhere in the world. In the United States alone, 5.8 million people are l... Read More |
|
THE 10 LATEST FDA ORPHAN DRUG DESIGNATIONS FOR CANCER TREATMENTS article Sep 25, 2019 The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions. The US Food and Drug Administration’s (FDA) Orphan Drug Designation (ODD) denotes medications that are potential promising treatments for rare diseases in th... Read More |
HOW DOES A DRUG FOR COLORECTAL CANCER WORK? article Sep 25, 2019 Colorectal cancer is a fatal and common disease, and treatment decisions are often based on what genes have been mutated in the development of the cancer. This means that certain patients with colorectal cancer may benefit from the chemotherapeutic ‘cetuximab’ while other patients may be... Read More |
COULD SMART PILL BOTTLES DISPENSE A SOLUTION TO DRUG NON-ADHERENCE? article Sep 25, 2019 To tackle the challenge of medication adherence, particularly in the clinical trial space, UK health tech company Elucid has created a smart pill bottle and mobile app called Pill Connect. Currently in the trial stage, Pharma Tech Focus talks to Elucid’s CEO Dr James Burnstone about how the sy... Read More |
REVIVING A DISCONTINUED DRUG article Sep 24, 2019 Most of the drugs that are taken off the market are removed for reasons other than safety. However, sometimes drug makers choose to remove drugs from the market even if there is no problem with their safety profile. In fact, from 1994 through 2015, 215 drugs were withdrawn from sale, and only 5.1 pe... Read More |
WHAT IS DXM? article Sep 24, 2019 A normal dosage of cough syrup has 15 to 30 milligrams of DXM. Most doctors recommend that you do not take more than 30 milligrams over a 24-hour period. It takes between 300 and 1,000 milligrams of DXM to get high. DXM can cause euphoria that ranges from a mild buzz to hallucination or an out-of-bo... Read More |
HOW A SINGLE PAYER SYSTEM CAN HELP SOLVE THE US OPIOID CRISIS article Sep 23, 2019 The US now has only a decade to achieve both universal health coverage and to prevent and treat substance abuse under the United Nations’ 2030 Sustainable Development Goals. Katherine Pettus argues that adopting a single-payer public health system is likely to be the only way to achieve these ... Read More |
|
HOW ATTRACTIVE ARE BIO-SIMILARS FOR PHARMA COMPANIES? article Sep 20, 2019 Biosimilar therapies are copies of large-molecule, biologic drugs. They differ from generics in that they are not exact copies of the original drug but, rather, a similar molecule that delivers an equivalent clinical outcome to the branded drug. Where small molecule drugs comprise 10s of atoms, biol... Read More |
ZOLGENSMA – MORE THAN JUST THE WORLD’S MOST EXPENSIVE DRUG article Sep 19, 2019 The US Food and Drug Administration (FDA) recently approved Zolgensma, Novartis’ one-dose gene therapy for the treatment of paediatric patients (less than two years of age) suffering from spinal muscular atrophy (SMA), a rare but life-threatening disease. Zolgensma was acquired by Novartis as ... Read More |
THE ENORMOUS POTENTIAL OF AI FOR PHARMACEUTICAL article Sep 18, 2019 The adoption of Artificial Intelligence (AI) in research-intensive organizations has essentially seen linear growth in recent years. Pharmaceutical, CRO, university and healthcare organizations are beginning to shift away from theoretical plans to genuine practical applications of machine intelligen... Read More |
DIFFERENCE BETWEEN OPIOIDS AND OPIATES article Sep 18, 2019 The difference between opioids and opiates is subtle enough that most people use the words interchangeably. After all, they both come from the poppy plant. The biggest difference is that opiates are natural drugs and opioids are synthetic drugs. They both have the same effect on the mind and can cau... Read More |
CBD MARKETING: HIGH MARKS FOR THE NEXT “IT” PRODUCT article Sep 18, 2019 CBD and products like it seem to be making an immediate splash in healthcare as of late. But, how has this controversial product gained such rapid success? Across the country more and more companies are popping up selling CBD products ranging from oils to dog treats. Read More |
BUILDING THE SMARTEST PHARMA COMPANY IN THE WORLD article Sep 17, 2019 The Finnish pharmaceutical company Orion Pharma, with help from Reaktor AI, has been on a journey to introduce AI into company operations across the board, to fully utilize all available data, and to build the capability to quickly adapt in an ever- changing world. In other words, their goal is to b... Read More |
KEY OPINION LEADERS article Sep 16, 2019 Key Opinion Leaders (KOLs) are experts in their field and a respected voice in medical circles. They have an influential quality coveted by companies within the pharmaceutical industry. In this blog, we look at the role of KOLs and the 5 steps to creating an effective partnership. A KOL is typically... Read More |
|
MEDICAL WRITING - WHAT IS IT? article Sep 12, 2019 This blog will give a brief insight into the discipline of medical writing, including the various types of writing and the skills deemed necessary by top medical writing companies. If you require high-quality scientific and medical writing services get in touch with Phil or Anna today - we are more ... Read More |
HOW A PHARMACEUTICAL COMPANY’S HIV RESEARCH BECAME IMMERSIVE THEATER article Sep 09, 2019 Four years ago, when ViiV Healthcare commissioned an ethnographic research study to understand the impact of HIV on black men in Baltimore and Jackson, Mississippi, the pharmaceutical company came away with a set of complex findings. Cultural identity, contextual environment, social structures and l... Read More |
WHAT ARE “COSMECEUTICALS”? article Sep 03, 2019 The term “cosmeceutical” has become popular in recent years to describe a cosmetic product that claims medicinal benefits. While those in the cosmetic industry use the term to advertise the ingredients and benefits of their products, the FDA does not legally recognize the term. According... Read More |
|
|
AI DRUG DISCOVERY CONSORTIUM JOINS FORCES WITH NVIDIA article Aug 08, 2019 Pharmaceutical companies have traditionally kept their data close to the vest because collaborations side effects may include compromising intellectual property and losing the edge over competitors. But sharing data has major perks. The more data a pharma company has at its disposal, the better equi... Read More |
|
DARK HISTORY OF BAYER CROP SCIENCE article Jul 21, 2019 Bayer AG is a German chemical and pharmaceutical company that was founded in 1863 by Friedrich Bayerand Johann Wescott in Barmen, Germany. The company is one of the largest producers of aspirin and enjoys selling variety of medications for diabetes, birth control and multivitamins. Although recently... Read More |
CHINA'S PHARMACEUTICAL MARKET EXPECTED TO BOOM IN COMING YEARS article Jul 09, 2019 In a recent panel discussion at the World Economic Forum’s Annual Meeting of the New Champions, held in Dalian, China, ethicists and biotech executives met to discuss a plan for the future of biotech. One of the issues discussed was whether the new big breakthrough in the industry, and the dom... Read More |
PHARMACEUTICAL PACKAGING SOLUTIONS AT UHLMAN’S PHARMAZING DAYS 2019 article Jul 09, 2019 The 2019 Uhlman’s Pharmazing Days were held in June at Uhlmann’s headquarters in Laupheim, Germany. Over 500 attendees visited, and over 20 exhibition partners showcased pharmaceutical packaging solutions that are integrated with Uhlmann’s systems. Uhlmann Pac-Systeme showed its pa... Read More |
HOT MELT EXTRUSION IN THE PHARMACEUTICAL AND FOOD INDUSTRIES article Jul 04, 2019 Hot melt extrusion is a manufacturing technique that was originally established in the early 1930s for use in the plastics and food industries but is now gaining popularity in the pharmaceutical industry as well. Around half of all plastics products are made using hot melt extrusion, which is the pr... Read More |
|
SIX DRUG-FREE TREATMENT OPTIONS FOR PEOPLE WITH COGNITIVE ILLNESSES article Jul 02, 2019 While cures may not currently be possible for many forms of cognitive illnesses, are there ways to treat people without the use of drugs? Some believe it is possible to help manage some of the challenging behaviors and symptoms with a number of drug-free treatment options, including holistic therapi... Read More |
PREMIER'S PROVIDEGX TO LAUNCH INTRAVENOUS NUTRITION DRUG article Jul 02, 2019 Premier subsidiary ProvideGx is now supplying cysteine hydrochloride injections to its member providers, the generic-drug division of the group purchasing and consulting organization announced Tuesday. ProvideGx teamed up with the manufacturer Exela Pharma Sciences to deliver the only Food and Drug ... Read More |
DATA PIPELINE SOLUTION ACCELERATES PHARMACEUTICAL RESEARCH article Jun 17, 2019 Pharmaceutical research is data-intensive. It takes tremendous computational power to parse and analyze the requisite giant chunks of data. The cloud delivers that power and helps accelerate research processes and, ultimately, research findings. That’s why one pharmaceutical company was using ... Read More |
VENATORX PHARMACEUTICALS TO PRESENT AT ASM MICROBE 2019 article Jun 17, 2019 VenatoRx Pharmaceuticals will present ten posters featuring its two development-stage products, cefepime/VNRX-5133 and ceftibuten/VNRX-7145, at ASM Microbe 2019 to be held June 20-24 in San Francisco, CA. VenatoRx will also present an overview if its antibacterial agents portfolio during the Pharma ... Read More |
|
|
|
THE EMERGING TIME OF AN AFRICAN COURT OF LAW article May 06, 2019 Open indictment of genocide and other crimes committed by white collor scientists in collaboration with governmental, medical, military and pharmaceutical establishments against Africans On the 4th of July, what a remarkable date, 2011, it becomes known that more and more African leaders and militar... Read More |
WILL PHARMACY BECOME A FIVE-YEAR DEGREE? article Apr 25, 2019 “This is the biggest change in pharmacy education and training since the profession moved in the mid-20th century from the apprenticeship route to become a degree-only profession,” says Marc Donovan, chief pharmacist at Boots. But the proposals from the General Pharmaceutical Council (GP... Read More |
SHOULD PHARMACY SELL E-CIGARETTES AND ENCOURAGE PEOPLE TO VAPE? article Apr 23, 2019 A smoking cessation expert and a pharmacist share their views on whether pharmacies should stock and recommend e-cigarettes to people who want to kick their tobacco habit. It’s been more than ten years since the UK’s public smoking ban pushed cigarette smokers out into the cold in 2007, ... Read More |
PATHAI RAISES $60M FOR DEEP LEARNING-BASED PATHOLOGY PROGRAMS article Apr 22, 2019 To help power its artificial intelligence-based pathology services, PathAI has raised $60 million in venture capital funding, with plans to accelerate its R&D into new digital tools and medical devices for the diagnosis and classification of diseases like cancer. In addition, the Boston-based co... Read More |
|
FIVE INDUSTRIES BEING TRANSFORMED BY ARTIFICIAL INTELLIGENCE article Apr 15, 2019 Technology is a transformative force, and there is currently no technology more transformative than AI. Because AI encompasses so many different fields -- from robotics to deep learning to self-driving cars -- it can be hard to quantify the exact impact it has had on the economy and on individual in... Read More |
THE UK AS A GLOBAL LEADER IN ANTIMICROBIAL RESISTANCE article Apr 15, 2019 The Government wants the UK to become a leader in the development of products which tackle the global challenge of antimicrobial resistance (AMR). Despite the renewal of the 5-year AMR Strategy, there is no time to wait before driving new antimicrobial innovations into the mainstream. There must be ... Read More |
PHARMACEUTICAL SUPPLIER OPTS FOR HYGIENIC FLOWMETER article Apr 15, 2019 Specialist process machinery manufacturer, L.B. Bohle, has developed a cleaning system for the pharmaceutical industry using Bürkert's innovative FloWave flowmeter for a compact, hygienic and very accurate process. Incorporating the latest in flow measurement technology has minimised equipm... Read More |
PICKING UP THE PIECES OF CONNECTICUT'S ECONOMY article Apr 12, 2019 Hop on a Metro-North out of New York City on the New Haven Line. Soon, you’ll hit the pristine picket fences and well-manicured mansions of Fairfield County — the wealthiest metropolitan area in the nation, where finance and industry titans rake in million-dollar incomes and send their c... Read More |
CORRECTION: IMPORTING PRESCRIPTION DRUGS STORY article Apr 12, 2019 TALLAHASSEE, Fla. (AP) — Floridians could eventually gain access to cheaper Canadian prescription drugs under legislation passed Thursday by the state House, a top priority of Republican Gov. Ron DeSantis. The GOP-led House voted 93-22 on Thursday for the measure, which if finalized creates a ... Read More |
LEVERAGING THE ROLE OF AI FOR MORE SUCCESSFUL CLINICAL TRIALS article Apr 04, 2019 The pharmaceutical industry spends billions on R&D each year. Clinical trials require tremendous amounts of effort, from identifying sites and enrolling patients to overseeing research functions and coordinating trial logistics. Trials often run over budget or are delayed because of a number of ... Read More |